Additional file 2: Table S2. of Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

Pleyer, Lisa; Burgstaller, Sonja; Stauder, Reinhard; Girschikofsky, Michael; Sill, Heinz; Schlick, Konstantin; Thaler, Josef; Halter, Britta; Machherndl-Spandl, Sigrid; Zebisch, Armin; Pichler, Angelika; PfeilstĂścker, Michael; Autzinger, Eva-Maria; Lang, Alois; Geissler, Klaus; Voskova, Daniela; Geissler, Dietmar; Sperr, Wolfgang; Hojas, Sabine; Rogulj, Inga; Andel, Johannes; Greil, Richard

doi:10.6084/m9.figshare.c.3611363_D1.v1

13045_2016_263_MOESM2_ESM.doc (40 kB)

Additional file 2: Table S2. of Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

journal contribution

posted on 2016-04-16, 05:00 authored by Lisa Pleyer, Sonja Burgstaller, Reinhard Stauder, Michael Girschikofsky, Heinz Sill, Konstantin Schlick, Josef Thaler, Britta Halter, Sigrid Machherndl-Spandl, Armin Zebisch, Angelika Pichler, Michael PfeilstĂścker, Eva-Maria Autzinger, Alois Lang, Klaus Geissler, Daniela Voskova, Dietmar Geissler, Wolfgang Sperr, Sabine Hojas, Inga Rogulj, Johannes Andel, Richard Greil

Treatment after azacitidine in young patients. (DOC 40 kb)

Funding

Celgene Ltd

History

Usage metrics

Keywords

AML MDS WHO FAB Classification RAEB-t Bone marrow blast count Azacitidine Austrian Azacitidine Registry

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: Table S2. of Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

Funding

Celgene Ltd

History

Usage metrics

Categories

Keywords

Licence

Exports